Currently, uniQure N.V [QURE] is trading at $47.5, up 247.73%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The QURE shares have gain 235.45% over the last week, with a monthly amount glided 205.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
uniQure N.V [NASDAQ: QURE] stock has seen the most recent analyst activity on August 14, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $30 for it. On December 10, 2024, upgrade upgraded it’s rating to Strong Buy. Goldman downgraded its rating to a Neutral but $8 remained the price target by the analyst firm on February 29, 2024. Mizuho downgraded its rating to Neutral for this stock on December 19, 2023, and downed its price target to $10. In a note dated March 17, 2022, UBS upgraded an Buy rating on this stock but restated the target price of $40.
This stock has fluctuated between a low of $4.45 and a high of $19.18 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $41 within the next 12 months. uniQure N.V [NASDAQ: QURE] shares were valued at $47.5 at the most recent close of the market. An investor can expect a potential drop of -13.68% based on the average QURE price forecast.
Analyzing the QURE fundamentals
Trailing Twelve Months sales for uniQure N.V [NASDAQ:QURE] were 14.34M which represents -52.71% decline. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at -11.81%, Pretax Profit Margin comes in at -13.76%, and Net Profit Margin reading is -13.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -10.11 and Total Capital is -0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -16.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.34 points at the first support level, and at 31.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 53.43, and for the 2nd resistance point, it is at 59.37.
Ratios To Look Out For
To put it in perspective, the Current Ratio for uniQure N.V [NASDAQ:QURE] is 9.98. Also, the Quick Ratio is 9.98, while the Cash Ratio stands at 6.2. Considering the valuation of this stock, the price to sales ratio is 181.74.
Transactions by insiders
Recent insider trading involved KLEMT CHRISTIAN, Officer, that happened on Sep 24 ’25 when 3000.0 shares were purchased. Director, Kapusta Matthew C completed a deal on Sep 24 ’25 to buy 0.23 million shares. Meanwhile, Chief Medical Officer Abi-Saab Walid sold 1466.0 shares on Jun 27 ’25.
